Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01)
קרן | National Cancer Institute/NIH |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 17/11/2018 |
פקולטה | Life Sciences, Medicine |
תיאור | This grant invites applications to establish research teams of the Small-Cell Lung Cancer (SCLC) Consortium to conduct research whose overall goals are: 1) to improve SCLC therapeutics, focusing on understanding how the molecular vulnerabilities of this cancer could be used to develop targeted agent combinations 2) to gain a better understanding of the rapid development of clinical resistance to drug and radiation therapy.
Funding: $450,000 total Duration: 5 years
LOI (encouraged) due dates: 17.2.16, 17.10.16, 17.2.17, 17.10.17, 17.2.18, 17.10.18 Full application due dates: 17.3.16, 17.11.16, 17.3.17, 17.11.17, 17.3.18, 17.11.18 |
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 08/12/2015 |